Mangrove Partners »

Adagio Therapeutics shares owned by Mangrove Partners

Quarter-by-quarter ownership of Adagio Therapeutics (IVVD) shares owned by Mangrove Partners from 13F filings

Historical chart of Mangrove Partners investment in Adagio Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Adagio Therapeutics held by Mangrove Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Adagio Therapeutics by Mangrove Partners

Quarter filed Position value Share count Share price at filing
2025-12-31 $104k 42k 2.47

More positions owned by Mangrove Partners

Indivior Ord
Rio Tinto Sponsored Adr (RIO)
Atmus Filtration Technologies Ord (ATMU)
Teva Pharmaceutical Inds Sponsored Ads (TEVA)
Ecovyst (ECVT)
Becton, Dickinson and (BDX)
Enova Intl (ENVA)
Flywire Corporation Com Vtg (FLYW)
Millrose Pptys Com Cl A (MRP)
PG&E Corporation (PCG)
Bio Rad Labs Cl A (BIO)
Bill Com Holdings Ord (BILL)
Elme Communities Sh Ben Int (ELME)
Fidelity National Information Services (FIS)
Rex American Resources (REX)

View all positions for Mangrove Partners

Top funds holding Adagio Therapeutics

Henderson Group
Maverick Capital
RA Capital Management
Point72 Asset Management
Mithril II GP
Vanguard Group
Driehaus Capital Management
M28 Capital Management
Saturn V Capital Management
Soleus Capital Management
Eventide Asset Management
State Street Corporation
Siren
ADAR1 Capital Management
BlackRock

View all funds holding Adagio Therapeutics